ARKG vs SCHB
ARK Genomic Revolution ETF vs Schwab US Broad Market ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SCHB—
Schwab US Broad Market ETF
Total US equity market.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SCHB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Schwab |
ARKG top holdings
Holdings data unavailable for ARKG.
SCHB top holdings
Holdings data unavailable for SCHB.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SCHB
SCHB (Schwab US Broad Market ETF) is Total US equity market.